Additional file 7 of Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells

Autor: L. Absil, F. Journé, D. Larsimont, J. J. Body, L. Tafforeau, Nonclercq, D.
Rok vydání: 2020
Předmět:
DOI: 10.6084/m9.figshare.12643658
Popis: Additional file 7: Supplementary Figure 7. BSP expression after different treatments during 48 h in MCF-7. BSP was evidenced by immunofluorescence and is expressed in the cytoplasm. Estrogens (E) and CDCA (CDCA) induced an increase of BSP expression compared to the control (C). 4-hydroxytamoxifen (T), fulvestrant (F), LCA (L) and Z-guggulsterone (G) caused no variation in BSP expression compared to the control (C). 4-hydroxytamoxifen and fulvestrant in combined with estrogens or CDCA (E + T, E + F, CDCA+T, CDCA+F) caused a decrease of BSP expression compared to estrogens (E) or CDCA (CDCA). LCA and Z-guggulsterone in combined with CDCA (CDCA+L, CDCA+G) caused a decrease in BSP expression compared to CDCA (CDCA). Scale bars = 100 μm.
Databáze: OpenAIRE